Assessing the performance of 68Ga-Fibroblast activating protein inhibitor-04 (FAPI) PET/CT in the diagnosis of cholangiocarcinoma - A prospective pilot study

被引:0
|
作者
Halanaik, D. [1 ]
Rajaraman, V. [1 ]
Meenakshi, L. Aridhasan [1 ]
Selvaraj, A. Jeba [1 ]
Pottakkat, B. [1 ]
机构
[1] Jawaharlal Inst Postgrad Med Educ & Res, Pondicherry, India
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OP-161
引用
收藏
页码:S72 / S73
页数:2
相关论文
共 50 条
  • [1] Assessing the performance of Ga-68-Fibroblast activating protein inhibitor-04 (FAPI) in the diagnosis the hepatobiliary malignancies (HBM)- A prospective pilot study
    Rajaraman, V.
    Jeba, A.
    Halanaik, D.
    Pottakkat, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S118 - S118
  • [2] Assessing the performance of Ga-68Fibroblast activating protein inhibitor04 (FAPI) in the diagnosis the cholangiocarcinoma
    Halanaik, Dhanapathi
    Meenakshi, Lakshman Aridhasan
    Rajaraman, Vishnukumar
    Pottakkat, Biju
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [3] A pilot study of [68Ga]Ga-fibroblast activation protein inhibitor-04 PET/CT in renal cell carcinoma
    Guo, Chunmei
    Liu, Ya
    Yang, Haozhou
    Xia, Yuxiao
    Li, Xue
    Chen, Liming
    Feng, Yue
    Zhang, Yan
    Chen, Yue
    Huang, Zhanwen
    BRITISH JOURNAL OF RADIOLOGY, 2024, 97 (1156): : 859 - 867
  • [4] 68Ga-FAPI-04 PET/CT in Assessment of Fibroblast Activation in Keloids: A Prospective Pilot Study
    Wang, Jiarou
    Yu, Nanze
    Wang, Guochang
    Wang, Rongxi
    Li, Linlin
    Jiang, Yuanyuan
    Sui, Huimin
    Sun, Yixin
    Li, Zhijin
    Long, Xiao
    Zhu, Zhaohui
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (01) : 16 - 22
  • [5] Role of 68Ga-fibroblast activation protein inhibitor (FAPI) PET/CT in the evaluation of peritoneal carcinomatosis and comparison with 18F-FDG PET/CT
    Chen, Haojun
    Zhao, Liang
    Pang, Yizhen
    Sun, Long
    Wu, Hua
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [6] 68Ga-fibroblast activation protein inhibitor PET/CT on GTV delineation of oesophageal cancer
    Zhao, L.
    Chen, H.
    Lin, Q.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S1503 - S1504
  • [7] 68Ga-FAPI-04 PET/CT for the Evaluation of Cholangiocarcinoma: Comparison With 18F-FDG PET/CT and Abdominal 68Ga-FAPI-04 PET/MR
    Zhang, Zeyu
    Cheng, Chao
    Jiang, Hui
    Pan, Guixia
    Yu, Yong
    Jin, Gang
    Zuo, Changjing
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (05) : 409 - 418
  • [8] Role of 68Ga-FAPI PET/CT in Assessing Hepatobiliary Malignancies A Prospective Pilot Study
    Rajaraman, Vishnukumar
    Meenakshi, Lakshman Aridhasan
    Selvaraj, Ashwin Jeba
    Pottakkat, Biju
    Halanaik, Dhanapathi
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (06) : E281 - E288
  • [9] The earliest optimal timing for total-body 68Ga-fibroblast activation protein inhibitor-04 PET scans: an evidence-based single-centre study
    Zheng, Zhe
    Gao, Huaping
    Lin, Yu
    Yu, Haojun
    Mao, Wujian
    Yang, Runjun
    He, Yibo
    Chen, Xueqi
    Wu, Ha
    Hu, Pengcheng
    Shi, Hongcheng
    EUROPEAN RADIOLOGY, 2024, 34 (07) : 4550 - 4560
  • [10] Fibroblast imaging of hepatic carcinoma with68Ga-FAPI-04 PET/CT: a pilot study in patients with suspected hepatic nodules
    Shi, Ximin
    Xing, Haiqun
    Yang, Xiaobo
    Li, Fang
    Yao, Shaobo
    Zhang, Hui
    Zhao, Haitao
    Hacker, Marcus
    Huo, Li
    Li, Xiang
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (01) : 196 - 203